Drug Watch: Agents in late-stage development for the treatment of adult and juvenile rheumatoid arthritis (July 2008) (PDF)

News
Article

Drugs in development for the treatment of adult and juvenile rheumatoid arthritis

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Eydenzelt, Additional Eylea Biosimilar

FDA Approves Eydenzelt, Additional Eylea Biosimilar

Logan Lutton
October 12th 2025
Article

Read More

Repatha Now Available for Approximately 60% Off List Price

Repatha Now Available for Approximately 60% Off List Price

Logan Lutton
October 12th 2025
Article

Read More

Medicine Nobel Prize Goes to Researchers Who Made Autoimmune Breakthrough

Medicine Nobel Prize Goes to Researchers Who Made Autoimmune Breakthrough

Logan Lutton
October 12th 2025
Article

Read More

ALS May Be Autoimmune Disease, Study Shows

ALS May Be Autoimmune Disease, Study Shows

Logan Lutton
October 12th 2025
Article

Read More

A Conversation with Francesca Bridge, MBBS, Neurologist at Alfred Health in Melbourne, Australia and Ph.D. Candidate at Monash University

A Conversation with Francesca Bridge, MBBS, Neurologist at Alfred Health in Melbourne, Australia and Ph.D. Candidate at Monash University

Logan Lutton
October 12th 2025
Article

Read More

FDA Approves Chronic Spontaneous Urticaria Drug, Rhapsido

FDA Approves Chronic Spontaneous Urticaria Drug, Rhapsido

Logan Lutton
October 12th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.